Compare RGNX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGNX | PMT |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 812.7M |
| IPO Year | 2015 | 2009 |
| Metric | RGNX | PMT |
|---|---|---|
| Price | $7.45 | $8.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $28.75 | $13.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.33% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | $10,393,000.00 | ★ $351,067,000.00 |
| Revenue This Year | $51.21 | N/A |
| Revenue Next Year | $19.08 | $1.55 |
| P/E Ratio | ★ N/A | $20.18 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $7.97 |
| 52 Week High | $16.19 | $13.80 |
| Indicator | RGNX | PMT |
|---|---|---|
| Relative Strength Index (RSI) | 34.34 | 23.82 |
| Support Level | $5.67 | N/A |
| Resistance Level | $11.43 | $9.80 |
| Average True Range (ATR) | 0.45 | 0.22 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 12.07 | 10.37 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.